Learn more

TIANJIN INST OF PHARMACEUTICAL RES

Overview
  • Total Patents
    17
  • GoodIP Patent Rank
    110,846
About

TIANJIN INST OF PHARMACEUTICAL RES has a total of 17 patent applications. Its first patent ever was published in 2013. It filed its patents most often in China, EPO (European Patent Office) and United States. Its main competitors in its focus markets organic fine chemistry, pharmaceuticals and environmental technology are HOLCO INVESTMENT INC, CURTANA PHARMACEUTICALS INC and LUNDBECK LA JOLLA RESEARCH CENTER INC.

Patent filings in countries

World map showing TIANJIN INST OF PHARMACEUTICAL RESs patent filings in countries
# Country Total Patents
#1 China 15
#2 EPO (European Patent Office) 1
#3 United States 1

Patent filings per year

Chart showing TIANJIN INST OF PHARMACEUTICAL RESs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Xu Weiren 7
#2 Tang Lida 6
#3 Wang Yuli 4
#4 Zhu Xueyu 3
#5 Wu Jiang 3
#6 Zou Meixiang 3
#7 Liu Wei 3
#8 Zhang Tiejun 3
#9 Gao Hang 2
#10 Wang Lili 2

Latest patents

Publication Filing date Title
CN106138170A Melilotus officinalis extract and preparation method thereof, pharmaceutical composition and application
CN105982998A Medicine composition for treating fatty liver, and preparation method and purpose of medicine composition
CN105837681A Erythropoietin mimic peptide derivative, and preparation method and application thereof
CN105399800A Self-assembled polypeptide, preparation method, nucleic acid complex and uses thereof
CN105456867A Medicine composition for treating urinary incontinence and preparing method and application of medicine composition
CN105412186A Extracting preparation method for traditional Chinese medicinal material containing volatile oil and composition of traditional Chinese medicinal material
CN105362325A Traditional Chinese medicine chrysanthemum indicum extract and preparation method, pharmaceutical composition and application thereof
CN105362269A Saccharose containing roflumilast tablets and preparation method thereof
CN105362454A Composition with assistant blood glucose reducing function and preparation method and application thereof
CN105367525A Preparation method of substituted benzobfuran-2-formamide
CN105439873A 3-hydroxy-1-amantadine preparation method
CN105440017A Dabigatran etexilate vanillate and preparation method and application thereof
CN105367551A Dabigatran etexilate glycolate, preparation method and applications thereof
CN105362270A Anti-Noonan-syndrome uses of 2,4-dihydroxychalcone derivatives
CN105434422A Application of alpha and gamma-mangostin in preparation of antidepressant drug